Business

Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue

CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced continued operational growth and infrastructure expansion at Cosmofarm, its pharmaceutical distribution subsidiary in Greece. During 2025, Cosmofarm added nearly 100 new pharmacy customers, representing a weighted average increase of approximately 20% in its active customer base. This growth was accompanied b

articleCosmos Health Inc.January 20, 20264/company/cosmos-health-inc/news/cosmos-health-announces-accelerating-customer-154500206
Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue

About this update from Cosmos Health Inc.

[{"type":"image","alt":"Cosmos Health Inc.","displaySize":"","headline":null,"caption":"Cosmos Health Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":157,"url":"https://media.zenfs.com/en/globenewswire.com/340010e4b2fe348130647e37170a6c2a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/zU4V54zW1TjV8qFkho7Qmg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/340010e4b2fe348130647e37170a6c2a","width":300,"height":157}},"lazy":false},{"type":"text","content":"CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced continued operational growth and infrastructure expansion at Cosmofarm, its pharmaceutical distribution subsidiary in Greece.","length":325,"tagName":"p"},{"type":"text","content":"During 2025, Cosmofarm added nearly 100 new pharmacy customers, representing a weighted average increase of approximately 20% in its active customer base. This growth was accompanied by improved unit economics, with annual revenue per customer increasing by approximately 12% and profitability per customer improving by approximately 14%, driven by enhanced route density, optimized order execution, and increasing operational leverage. Based on current onboarding activity and demand trends, management expects customer growth in 2026 to continue at similar or higher rates.","length":575,"tagName":"p"},{"type":"text","content":"To further strengthen service quality and last-mile delivery performance, Cosmofarm introduced three new delivery routes within the Attica region, expanding geographic coverage and delivery frequency across one of Greece’s most densely populated pharmaceutical markets.","length":269,"tagName":"p"},{"type":"text","content":"Cosmofarm’s operating model is supported by multi-year, multi-million investments in automation and logistics infrastructure, including advanced ROWA and A-frame robotic systems for procurement, inventory management, and order fulfillment. A further capital investment program of approximately $1 million is currently underway, continuing prior initiatives to expand robotic capacity and throughput.","length":399,"tagName":"p"},{"type":"text","content":"ROWA and A-Frame Picking Line Extension Master Pla...

More updates from Cosmos Health Inc.

The CompanyCosmofarmpharmaceutical distributionCosmosGreeceCompanycustomer growth